期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肺癌与肺炎衣原体感染关系的研究 被引量：5

Clamydia Pneumoniae Infection and Lung Neoplasms
暂未订购
导出
摘要 目的:研究肺炎衣原体(Cpn)和肺癌之间的关系。方法:采用间接微量免疫荧光法检测肺癌标本43例和非肺癌呼吸科病人19例肺组织中Cpn特异性抗原。结果:肺癌组Cpn抗原表达水平明显高于对照组:肺癌组中Cpn-Ag阳性率88.4%(38/ 43),对照组阳性率26.3%(5/19),p<0.0001。结论:肺癌患者易患Cpn感染,Cpn感染与肺癌有一定的关系,值得临床重视。 Objective:To investigate the relationship between Chlamydia pnoumoniae(Cpn) infection and lung cancer. Methods: The Cpn-antigen was detected by microimmunofluorcscence tcchongue in 43 cases of lung cancer and 19 cases of normal lung tissue. Results:The rates of Cpn infection in patients with lung cancer were higher than those of patients without lung cancer:In lung cancer group and normal control.Cpn-Ag positive rate of were 88. 4%(38/43)and 26. 3% (5/19)respectively (p<0. 001). Conclusion: The lung cancer palicnls are liable to Cpn infection. There is a high incidence of Chlamydia pneumoniae in the patients with lung cancer. It may also play an important role in lung cancer.
作者 周妍 孙书明 胡志雄 金盈 徐坚 余竹元
机构地区 复旦大学附属金山医院呼吸内科 复旦大学附属金山医院职防科 复旦大学附属中山医院内科免疫室
出处 《中国临床医学》 北大核心 2005年第1期44-46,共3页 Chinese Journal of Clinical Medicine
关键词 肺癌患者 肺炎衣原体感染 对照组 阳性率 微量免疫荧光法 抗原表达 特异性抗原 目的 水平 Lung cancer Chlamydia pneumoniae Infection
分类号 R734.2 [医药卫生—肿瘤] R563 [医药卫生—呼吸系统]
  • 相关文献

参考文献11

  • 1王卫群,张瑞华,龚辉,余竹元.外周血单核细胞中肺炎衣原体特异性抗原的检测[J].中国临床医学,2002,9(3):243-245. 被引量：15
  • 2Muhlestain JB, Hammond EH, Carlquist JF, et al. Increased incidence symptomatic atherosclerotic versus other forms of cardiovascular disease[J]. J Am Coll Cardiol, 1996,27:1555-1561.?A
  • 3Messmer TO,Martinez J,Hassouna F,et al. Comparison of two commericial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immoglobulin G antibodies to Chlamydia pneumoniae[J]. Clin Diagn Lab Immuol, 2001,8(3) :588-592.
  • 4Cook PJ, Honeybourne D. Aspects of Chlamydia pneumoniae infection[J]. Presse Med, 1995,24(5) :278-282.
  • 5Grayston JT, Campbell LA,Kuo CC,et al. A new respiratory tract pathogen:Chlamydia pneumoniae strain TWAR[J]. JID,1990,161:618-625.
  • 6Koyi H,Branden E,Gnarpe J,et al. Chlamydia pneumoniae may be associated with lung cancer[J]. APMIS, 1999, 107(9):828-832.
  • 7Blasi F, Rizzato G, Gambacorta M, et al. Failure to detect the presence of Chlamydia pneumoniae in sarcoid pathology specimens[J]. Eur Respir J, 1997,10(11): 2609-2611.
  • 8Mayer LM, Woods ML, Varin Z, et al. Gamma interferon induced nitric oxide production reduces Chlamydia. trachomaatis infectivity in McCoy cells[J]. Infect. Immunol, 1993,61: 491.
  • 9Arroyo PL. Hath PV, Mower HF, et al. Mutagenicity of nitric oxide and its inhibition by antioxidants[J]. Mutation Res, 1992,281:193.
  • 10Jenkins DC, Charles IG, Baylis SA, et al. Human colon cancer cell generation lines slow a diverse pattern of nitric oxide synthase gene expression and nitric oxide[J]. Br J Cancer, 1994,70:847.

二级参考文献11

  • 1[1]Heick A, Striver E. Chlamydia penumoniae - associated A DEM. Eur J Neurol, 2000,7(4) :435 ～438.
  • 2[2]Rubegni P, Marano MR, De Aloe G. et al. Sweet's syndrome and Chlamydia pneumoniae infection. J Am Acad Dermatol,2001, 44(5) :862～864.
  • 3[3]Bodetti TJ, Timms P. Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of hu mans and koalas. Infect Immun, 2000, 68(5) :2744～2747.
  • 4[4]Moazed TC, Kuo CC, Grayston JT, et al. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infec Dis, 1998, 177:1322～1325.
  • 5[5]Muhlestain JB, Hammond EH, Carlquist JF, et al. Increased incidence of chlamydia species with in the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol, 1996; 27: 1555～1561.
  • 6[6]Wang SP, Kuo CC, Grayston JT. Formalinized Chlamydia tra chomatis organisms as antigen in the micro - immunofluo reseence test. J Clin Microbiol, 1979, 10:259～261.
  • 7[7]Messmer TO, Martinez J, Hassouna F, et al. Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G anti bodies to Chlamydia pneumoniae. Clin Diagn Lab Immnuol,2001, 8(3) :588～592.
  • 8[8]Persson K, Boman J. Comparison of five serologic tests for diag nosis of acute infections by Chlamydia pneumoniae. Clin Diagn Lab Immnuol, 2000, 7(5);739～744.
  • 9[9]Verkooyen RP, Sijmons M, Fries E, et al. Widely used, com mercially available Chlamydia pneumoniae antigen contaminated with mycoplasma. J Med Microbiol, 1997, 46:419～424.
  • 10[10]Grayston JT. Chlamydia pneumoniae, stain TWAR. Chest,1989, 95:664～669.

共引文献14

同被引文献77

引证文献5

二级引证文献10

中国临床医学
2005年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部